Abstract
The Medicines and Healthcare products Regulatory Agency (MHRA) is reviewing data suggesting that genetic changes triggered by sodium valproate could be passed down through generations. As part of its safety review into the epilepsy drug, the MHRA has confirmed it has asked the Commission on Human Medicines (CHM) — an independent expert panel — to […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
